Eintrag weiter verarbeiten
Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic
Gespeichert in:
| Zeitschriftentitel: | Colorectal Disease |
|---|---|
| In: | Colorectal Disease, 23, 2021, 3, S. 732-749 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| spelling |
1462-8910 1463-1318 Wiley Gastroenterology http://dx.doi.org/10.1111/codi.15431 <jats:title>Abstract</jats:title><jats:sec><jats:title>Aim</jats:title><jats:p>This study aimed to describe the change in surgical practice and the impact of SARS‐CoV‐2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS‐CoV‐2 pandemic.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>This was an international cohort study of patients undergoing elective resection of colon or rectal cancer without preoperative suspicion of SARS‐CoV‐2. Centres entered data from their first recorded case of COVID‐19 until 19 April 2020. The primary outcome was 30‐day mortality. Secondary outcomes included anastomotic leak, postoperative SARS‐CoV‐2 and a comparison with prepandemic European Society of Coloproctology cohort data.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>From 2073 patients in 40 countries, 1.3% (27/2073) had a defunctioning stoma and 3.0% (63/2073) had an end stoma instead of an anastomosis only. Thirty‐day mortality was 1.8% (38/2073), the incidence of postoperative SARS‐CoV‐2 was 3.8% (78/2073) and the anastomotic leak rate was 4.9% (86/1738). Mortality was lowest in patients without a leak or SARS‐CoV‐2 (14/1601, 0.9%) and highest in patients with both a leak and SARS‐CoV‐2 (5/13, 38.5%). Mortality was independently associated with anastomotic leak (adjusted odds ratio 6.01, 95% confidence interval 2.58–14.06), postoperative SARS‐CoV‐2 (16.90, 7.86–36.38), male sex (2.46, 1.01–5.93), age >70 years (2.87, 1.32–6.20) and advanced cancer stage (3.43, 1.16–10.21). Compared with prepandemic data, there were fewer anastomotic leaks (4.9% versus 7.7%) and an overall shorter length of stay (6 versus 7 days) but higher mortality (1.7% versus 1.1%).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Surgeons need to further mitigate against both SARS‐CoV‐2 and anastomotic leak when offering surgery during current and future COVID‐19 waves based on patient, operative and organizational risks.</jats:p></jats:sec> Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic Colorectal Disease |
|---|---|
| doi_str_mv |
10.1111/codi.15431 |
| facet_avail |
Online |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9jb2RpLjE1NDMx |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9jb2RpLjE1NDMx |
| institution |
DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 DE-15 |
| imprint |
Wiley, 2021 |
| imprint_str_mv |
Wiley, 2021 |
| issn |
1462-8910 1463-1318 |
| issn_str_mv |
1462-8910 1463-1318 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
2021outcomesfromelectivecolorectalcancersurgeryduringthesarscov2pandemic |
| publishDateSort |
2021 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Colorectal Disease |
| spellingShingle |
Colorectal Disease Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic Gastroenterology |
| source_id |
49 |
| title |
Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_unstemmed |
Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_full |
Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_fullStr |
Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_full_unstemmed |
Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_short |
Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_sort |
outcomes from elective colorectal cancer surgery during the sars‐cov‐2 pandemic |
| topic |
Gastroenterology |
| url |
http://dx.doi.org/10.1111/codi.15431 |
| publishDate |
2021 |
| physical |
732-749 |
| description |
<jats:title>Abstract</jats:title><jats:sec><jats:title>Aim</jats:title><jats:p>This study aimed to describe the change in surgical practice and the impact of SARS‐CoV‐2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS‐CoV‐2 pandemic.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>This was an international cohort study of patients undergoing elective resection of colon or rectal cancer without preoperative suspicion of SARS‐CoV‐2. Centres entered data from their first recorded case of COVID‐19 until 19 April 2020. The primary outcome was 30‐day mortality. Secondary outcomes included anastomotic leak, postoperative SARS‐CoV‐2 and a comparison with prepandemic European Society of Coloproctology cohort data.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>From 2073 patients in 40 countries, 1.3% (27/2073) had a defunctioning stoma and 3.0% (63/2073) had an end stoma instead of an anastomosis only. Thirty‐day mortality was 1.8% (38/2073), the incidence of postoperative SARS‐CoV‐2 was 3.8% (78/2073) and the anastomotic leak rate was 4.9% (86/1738). Mortality was lowest in patients without a leak or SARS‐CoV‐2 (14/1601, 0.9%) and highest in patients with both a leak and SARS‐CoV‐2 (5/13, 38.5%). Mortality was independently associated with anastomotic leak (adjusted odds ratio 6.01, 95% confidence interval 2.58–14.06), postoperative SARS‐CoV‐2 (16.90, 7.86–36.38), male sex (2.46, 1.01–5.93), age >70 years (2.87, 1.32–6.20) and advanced cancer stage (3.43, 1.16–10.21). Compared with prepandemic data, there were fewer anastomotic leaks (4.9% versus 7.7%) and an overall shorter length of stay (6 versus 7 days) but higher mortality (1.7% versus 1.1%).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Surgeons need to further mitigate against both SARS‐CoV‐2 and anastomotic leak when offering surgery during current and future COVID‐19 waves based on patient, operative and organizational risks.</jats:p></jats:sec> |
| container_issue |
3 |
| container_start_page |
732 |
| container_title |
Colorectal Disease |
| container_volume |
23 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792344358432800780 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T17:06:20.734Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Outcomes+from+elective+colorectal+cancer+surgery+during+the+SARS%E2%80%90CoV%E2%80%902+pandemic&rft.date=2021-03-01&genre=article&issn=1463-1318&volume=23&issue=3&spage=732&epage=749&pages=732-749&jtitle=Colorectal+Disease&atitle=Outcomes+from+elective+colorectal+cancer+surgery+during+the+SARS%E2%80%90CoV%E2%80%902+pandemic&rft_id=info%3Adoi%2F10.1111%2Fcodi.15431&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792344358432800780 |
| container_issue | 3 |
| container_start_page | 732 |
| container_title | Colorectal Disease |
| container_volume | 23 |
| description | <jats:title>Abstract</jats:title><jats:sec><jats:title>Aim</jats:title><jats:p>This study aimed to describe the change in surgical practice and the impact of SARS‐CoV‐2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS‐CoV‐2 pandemic.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>This was an international cohort study of patients undergoing elective resection of colon or rectal cancer without preoperative suspicion of SARS‐CoV‐2. Centres entered data from their first recorded case of COVID‐19 until 19 April 2020. The primary outcome was 30‐day mortality. Secondary outcomes included anastomotic leak, postoperative SARS‐CoV‐2 and a comparison with prepandemic European Society of Coloproctology cohort data.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>From 2073 patients in 40 countries, 1.3% (27/2073) had a defunctioning stoma and 3.0% (63/2073) had an end stoma instead of an anastomosis only. Thirty‐day mortality was 1.8% (38/2073), the incidence of postoperative SARS‐CoV‐2 was 3.8% (78/2073) and the anastomotic leak rate was 4.9% (86/1738). Mortality was lowest in patients without a leak or SARS‐CoV‐2 (14/1601, 0.9%) and highest in patients with both a leak and SARS‐CoV‐2 (5/13, 38.5%). Mortality was independently associated with anastomotic leak (adjusted odds ratio 6.01, 95% confidence interval 2.58–14.06), postoperative SARS‐CoV‐2 (16.90, 7.86–36.38), male sex (2.46, 1.01–5.93), age >70 years (2.87, 1.32–6.20) and advanced cancer stage (3.43, 1.16–10.21). Compared with prepandemic data, there were fewer anastomotic leaks (4.9% versus 7.7%) and an overall shorter length of stay (6 versus 7 days) but higher mortality (1.7% versus 1.1%).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Surgeons need to further mitigate against both SARS‐CoV‐2 and anastomotic leak when offering surgery during current and future COVID‐19 waves based on patient, operative and organizational risks.</jats:p></jats:sec> |
| doi_str_mv | 10.1111/codi.15431 |
| facet_avail | Online |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9jb2RpLjE1NDMx |
| imprint | Wiley, 2021 |
| imprint_str_mv | Wiley, 2021 |
| institution | DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15 |
| issn | 1462-8910, 1463-1318 |
| issn_str_mv | 1462-8910, 1463-1318 |
| language | English |
| last_indexed | 2024-03-01T17:06:20.734Z |
| match_str | 2021outcomesfromelectivecolorectalcancersurgeryduringthesarscov2pandemic |
| mega_collection | Wiley (CrossRef) |
| physical | 732-749 |
| publishDate | 2021 |
| publishDateSort | 2021 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Colorectal Disease |
| source_id | 49 |
| spelling | 1462-8910 1463-1318 Wiley Gastroenterology http://dx.doi.org/10.1111/codi.15431 <jats:title>Abstract</jats:title><jats:sec><jats:title>Aim</jats:title><jats:p>This study aimed to describe the change in surgical practice and the impact of SARS‐CoV‐2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS‐CoV‐2 pandemic.</jats:p></jats:sec><jats:sec><jats:title>Method</jats:title><jats:p>This was an international cohort study of patients undergoing elective resection of colon or rectal cancer without preoperative suspicion of SARS‐CoV‐2. Centres entered data from their first recorded case of COVID‐19 until 19 April 2020. The primary outcome was 30‐day mortality. Secondary outcomes included anastomotic leak, postoperative SARS‐CoV‐2 and a comparison with prepandemic European Society of Coloproctology cohort data.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>From 2073 patients in 40 countries, 1.3% (27/2073) had a defunctioning stoma and 3.0% (63/2073) had an end stoma instead of an anastomosis only. Thirty‐day mortality was 1.8% (38/2073), the incidence of postoperative SARS‐CoV‐2 was 3.8% (78/2073) and the anastomotic leak rate was 4.9% (86/1738). Mortality was lowest in patients without a leak or SARS‐CoV‐2 (14/1601, 0.9%) and highest in patients with both a leak and SARS‐CoV‐2 (5/13, 38.5%). Mortality was independently associated with anastomotic leak (adjusted odds ratio 6.01, 95% confidence interval 2.58–14.06), postoperative SARS‐CoV‐2 (16.90, 7.86–36.38), male sex (2.46, 1.01–5.93), age >70 years (2.87, 1.32–6.20) and advanced cancer stage (3.43, 1.16–10.21). Compared with prepandemic data, there were fewer anastomotic leaks (4.9% versus 7.7%) and an overall shorter length of stay (6 versus 7 days) but higher mortality (1.7% versus 1.1%).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Surgeons need to further mitigate against both SARS‐CoV‐2 and anastomotic leak when offering surgery during current and future COVID‐19 waves based on patient, operative and organizational risks.</jats:p></jats:sec> Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic Colorectal Disease |
| spellingShingle | Colorectal Disease, Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic, Gastroenterology |
| title | Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_full | Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_fullStr | Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_full_unstemmed | Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_short | Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| title_sort | outcomes from elective colorectal cancer surgery during the sars‐cov‐2 pandemic |
| title_unstemmed | Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic |
| topic | Gastroenterology |
| url | http://dx.doi.org/10.1111/codi.15431 |